|1.||Herzog, Herbert: 22 articles (06/2014 - 05/2002)|
|2.||Morris, Margaret J: 15 articles (01/2013 - 10/2003)|
|3.||Yada, Toshihiko: 12 articles (08/2015 - 04/2003)|
|4.||Beck-Sickinger, Annette G: 12 articles (07/2015 - 09/2005)|
|5.||Zukowska, Zofia: 11 articles (06/2013 - 02/2003)|
|6.||Meguid, Michael M: 11 articles (09/2008 - 01/2003)|
|7.||Mathé, Aleksander A: 10 articles (02/2015 - 01/2004)|
|8.||During, Matthew J: 9 articles (03/2010 - 03/2004)|
|9.||Tilan, Jason U: 8 articles (03/2015 - 07/2007)|
|10.||Sainsbury, Amanda: 8 articles (06/2014 - 01/2002)|
|1.||AIDS-Related Complex (ARC)
11/01/2003 - "Neuropeptide Y (NPY)-producing neurons in the hypothalamic arcuate nucleus (ARC) have been implicated in GH feedback in several studies in rats. "
03/01/2014 - "Within the hypothalamic arcuate nucleus (ARC), fasting increased cfos activation in ∼25% of neuropeptide Y neurons, which was terminated 1 hour after refeeding. "
04/01/2013 - "on 45% or 60% fat diet were heavier and fatter than controls, and had reduced neuropeptide Y (NPY) gene expression in the ARC. "
01/01/2013 - "In support of these findings, double-label immunohistochemistry indicated substantial coexpression of neuropeptide Y (NPY)- and Arc-immunoreactivity in Fos-positive neurons. "
11/01/2012 - "Orexigenic neuropeptide Y expressing ARC neurons are activated by food deprivation and inhibited by feeding in a nutrient-dependent manner. "
|2.||Body Weight (Weight, Body)
05/02/2006 - "A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice."
02/01/1989 - "Organ weights, body weight and neuropeptide Y (NPY) content in brain regions were determined at the end of the study. "
10/01/2015 - "Orexigenic actions mediated by neuropeptide-Y (NPY) promote body weight regulation. "
08/01/2012 - "The neuropeptide Y (NPY) has been suggested to act as a major regulator of emotional processes and body weight. "
06/10/2012 - "Plasma neuropeptide Y levels relate cigarette smoking and smoking cessation to body weight regulation."
03/01/1998 - "[Seizure-linked hippocampal plasticity and protection against excitotoxicity: possible role of neuropeptide-y]."
11/22/2002 - "Previous studies show that neuropeptide Y (NPY) inhibits in vitro seizures in rodent hippocampus. "
01/01/2002 - "Functional studies in epileptic tissue indicate that neuropeptide Y and some of its peptide analogs potently inhibit seizure activity. "
07/07/2000 - "Recent studies reported changes in neuropeptide Y (NPY) expression induced by seizures in the experimental epileptic models. "
01/01/2015 - "Many mouse models of the disease also present neuronal network hypersynchrony, as evidenced by higher susceptibility to pharmacologically-induced seizures, electroencephalographic seizures accompanied by spontaneous interictal spikes and expression of markers of chronic seizures such as neuropeptide Y ectopic expression in mossy fibers. "
|4.||Weight Loss (Weight Reduction)
05/01/2001 - "The aim of the study is the assessment whether weight loss treatment with adrenergic modulation drugs modifies neuropeptide Y (NPY) plasma concentration in obese women. "
06/01/2003 - "Postnatal intracerebroventricular exposure to neuropeptide Y causes weight loss in female adult rats."
05/01/1991 - "Increased central hypothalamic levels of neuropeptide Y in food-restricted rats suggest that this peptide may help to defend body weight by stimulating eating after weight loss."
12/20/2005 - "Despite numerous experiments showing that administration of neuropeptide Y (NPY) to rodents stimulates feeding and obesity, whereas acute interference with NPY signaling disrupts feeding and promotes weight loss, NPY-null mice have essentially normal body weight regulation. "
05/01/1994 - "Hypothalamic neuropeptide Y (NPY) may be involved in the hyperphagia that follows food deprivation associated with significant weight loss. "
|5.||Hypertension (High Blood Pressure)
09/01/2003 - "The aim of this study was to assess changes of plasma concentration of neuropeptide Y in patients with hypertension after exercise. "
07/01/1995 - "The aim or the study was to assess plasma neuropeptide Y immunoreactivity concentration (NPY-ir) during dynamic exercise in pts with different stages of essential hypertension (ESH). "
06/01/1994 - "Our study shows that plasma ET-1 and neuropeptide Y levels are elevated in patients with essential hypertension compared with a control group. "
09/01/1993 - "Thus, the present study indicates that neuropeptide Y is involved only slightly in the maintenance of high blood pressure in SHR."
01/01/2015 - "We hypothesized that Neuropeptide Y (NPY), which is a potent mitogenic peptide, participates in modulating proliferation and migration of VSMCs during hypertension in pregnancy. "
|1.||Somatostatin (Somatotropin Release-Inhibiting Factor)
|3.||Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
|5.||Calcitonin Gene-Related Peptide
|3.||Drug Therapy (Chemotherapy)
|4.||Surgical Instruments (Clip)
|5.||Transplantation (Transplant Recipients)